Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
iTeos and GSK's combination therapy FDA approval by end of 2024?  | Binary | 3 | 3 months ago | ||
First company to receive FDA approval for anti-TIGIT therapy for lung cancer by end of 2025? | Categorical | 3 | 3 months ago | ||
Significant improvement in overall survival rates in final GALAXIES Lung-201 study results by June 30, 2025? | Binary | 2 | 3 months ago | ||
TIGIT widely accepted as target for lung cancer treatment in clinical guidelines by end of 2025? | Binary | 2 | 3 months ago | ||
Objective response rate in final GALAXIES Lung-201 study results by June 30, 2025? | Categorical | 2 | 3 months ago | ||
Next major milestone announced for iTeos and GSK's combination therapy by end of 2024? | Categorical | 2 | 3 months ago |